1
|
Melgoza-González EA, Bustamante-Córdova L, Hernández J. Recent advances in antigen targeting to antigen-presenting cells in veterinary medicine. Front Immunol 2023; 14:1080238. [PMID: 36969203 PMCID: PMC10038197 DOI: 10.3389/fimmu.2023.1080238] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/26/2022] [Accepted: 02/27/2023] [Indexed: 03/12/2023] Open
Abstract
Advances in antigen targeting in veterinary medicine have gained traction over the years as an alternative approach for diseases that remain a challenge for traditional vaccines. In addition to the nature of the immunogen, antigen-targeting success relies heavily on the chosen receptor for its direct influence on the elicited response that will ensue after antigen uptake. Different approaches using antibodies, natural or synthetic ligands, fused proteins, and DNA vaccines have been explored in various veterinary species, with pigs, cattle, sheep, and poultry as the most frequent models. Antigen-presenting cells can be targeted using a generic approach, such as broadly expressed receptors such as MHC-II, CD80/86, CD40, CD83, etc., or focused on specific cell populations such as dendritic cells or macrophages (Langerin, DC-SIGN, XCR1, DC peptides, sialoadhesin, mannose receptors, etc.) with contrasting results. Interestingly, DC peptides show high specificity to DCs, boosting activation, stimulating cellular and humoral responses, and a higher rate of clinical protection. Likewise, MHC-II targeting shows consistent results in enhancing both immune responses; an example of this strategy of targeting is the approved vaccine against the bovine viral diarrhea virus in South America. This significant milestone opens the door to continuing efforts toward antigen-targeting vaccines to benefit animal health. This review discusses the recent advances in antigen targeting to antigen-presenting cells in veterinary medicine, with a special interest in pigs, sheep, cattle, poultry, and dogs.
Collapse
|
2
|
Status and Challenges for Vaccination against Avian H9N2 Influenza Virus in China. Life (Basel) 2022; 12:life12091326. [PMID: 36143363 PMCID: PMC9505450 DOI: 10.3390/life12091326] [Citation(s) in RCA: 23] [Impact Index Per Article: 7.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/08/2022] [Revised: 08/23/2022] [Accepted: 08/24/2022] [Indexed: 12/14/2022] Open
Abstract
In China, H9N2 avian influenza virus (AIV) has become widely prevalent in poultry, causing huge economic losses after secondary infection with other pathogens. Importantly, H9N2 AIV continuously infects humans, and its six internal genes frequently reassort with other influenza viruses to generate novel influenza viruses that infect humans, threatening public health. Inactivated whole-virus vaccines have been used to control H9N2 AIV in China for more than 20 years, and they can alleviate clinical symptoms after immunization, greatly reducing economic losses. However, H9N2 AIVs can still be isolated from immunized chickens and have recently become the main epidemic subtype. A more effective vaccine prevention strategy might be able to address the current situation. Herein, we analyze the current status and vaccination strategy against H9N2 AIV and summarize the progress in vaccine development to provide insight for better H9N2 prevention and control.
Collapse
|
3
|
Shrestha A, Sadeyen JR, Lukosaityte D, Chang P, Smith A, Van Hulten M, Iqbal M. Selectively targeting haemagglutinin antigen to chicken CD83 receptor induces faster and stronger immunity against avian influenza. NPJ Vaccines 2021; 6:90. [PMID: 34267228 PMCID: PMC8282863 DOI: 10.1038/s41541-021-00350-3] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/14/2021] [Accepted: 06/11/2021] [Indexed: 02/06/2023] Open
Abstract
The immunogenicity and protective efficacy of vaccines can be enhanced by the selective delivery of antigens to the antigen-presenting cells (APCs). In this study, H9N2 avian influenza virus haemagglutinin (HA) antigen, was targeted by fusing it to single-chain fragment variable (scFv) antibodies specific to CD83 receptor expressed on chicken APCs. We observed an increased level of IFNγ, IL6, IL1β, IL4, and CxCLi2 mRNA upon stimulation of chicken splenocytes ex vivo by CD83 scFv targeted H9HA. In addition, CD83 scFv targeted H9HA induced higher serum haemagglutinin inhibition activity and virus neutralising antibodies compared to untargeted H9HA, with induction of antibodies as early as day 6 post primary vaccination. Furthermore, chickens vaccinated with CD83 scFv targeted H9HA showed reduced H9N2 challenge virus shedding compared to untargeted H9HA. These results suggest that targeting antigens to CD83 receptors could improve the efficacy of poultry vaccines.
Collapse
Affiliation(s)
- Angita Shrestha
- grid.63622.330000 0004 0388 7540The Pirbright Institute, Pirbright, Woking, Surrey, United Kingdom ,grid.4991.50000 0004 1936 8948Department of Zoology, Peter Medawar Building, University of Oxford, Oxford, United Kingdom
| | - Jean-Remy Sadeyen
- grid.63622.330000 0004 0388 7540The Pirbright Institute, Pirbright, Woking, Surrey, United Kingdom
| | - Deimante Lukosaityte
- grid.63622.330000 0004 0388 7540The Pirbright Institute, Pirbright, Woking, Surrey, United Kingdom
| | - Pengxiang Chang
- grid.63622.330000 0004 0388 7540The Pirbright Institute, Pirbright, Woking, Surrey, United Kingdom
| | - Adrian Smith
- grid.4991.50000 0004 1936 8948Department of Zoology, Peter Medawar Building, University of Oxford, Oxford, United Kingdom
| | - Marielle Van Hulten
- grid.420097.80000 0004 0407 6096Global Poultry R&D Biologicals Boxmeer, Intervet International BV, MSD Animal Health, Boxmeer, The Netherlands
| | - Munir Iqbal
- grid.63622.330000 0004 0388 7540The Pirbright Institute, Pirbright, Woking, Surrey, United Kingdom
| |
Collapse
|
4
|
DNA aptamer-based rolling circle amplification product as a novel immunological adjuvant. Sci Rep 2020; 10:22282. [PMID: 33335251 PMCID: PMC7747709 DOI: 10.1038/s41598-020-79420-w] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/09/2020] [Accepted: 11/30/2020] [Indexed: 11/15/2022] Open
Abstract
Several agonists to CD40 have shown to induce acquired immune responses. Here, we developed and evaluated the rolling circle amplification (RCA) products that are based on anti-CD40 DNA aptamers as a novel vaccine adjuvant. First, we developed DNA aptamers with specific binding affinity to chicken CD40 extra domain (chCD40ED). Next, we prepared the RCA products that consist of these aptamers to increase the spanning space and overall binding affinity to chCD40ED. Using 8 DNA aptamer candidates, 4 aptamer-based RCA products (aptamer RCAs) were generated, each consisting of two distinct aptamers. We demonstrated that all 4 aptamer RCAs significantly induced the signal transduction in chicken HD11 macrophage cell line (p < 0.05). Finally, we conjugated one of the aptamer RCAs (Aptamer RCA II) to M2e epitope peptide of influenza virus as a model hapten, and the immune complex was injected to chickens. Aptamer RCA II stimulated anti-M2e IgG antibody production to the level significantly higher as compared to the control (M2e epitope alone; p < 0.05). The results of our work suggest that aptamer RCA is a novel platform to boost the efficacy of vaccines, which might find broad applications to other antigens beyond M2e epitope evaluated in this study using chicken infection model.
Collapse
|
5
|
High selective purification of IgY from quail egg: Process design and quantification of deep eutectic solvent based ultrasound assisted liquid phase microextraction coupled with preparative chromatography. Int J Biol Macromol 2020; 146:253-262. [DOI: 10.1016/j.ijbiomac.2019.12.242] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/23/2019] [Revised: 12/27/2019] [Accepted: 12/27/2019] [Indexed: 02/06/2023]
|
6
|
Duff A, Vuong C, Searer K, Briggs W, Wilson K, Hargis B, Berghman L, Bielke L. Preliminary studies on development of a novel subunit vaccine targeting Clostridium perfringens mucolytic enzymes for the control of necrotic enteritis in broilers. Poult Sci 2019; 98:6319-6325. [PMID: 31392320 PMCID: PMC8913755 DOI: 10.3382/ps/pez448] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/24/2019] [Accepted: 07/23/2019] [Indexed: 01/27/2023] Open
Abstract
Necrotic enteritis (NE) is a pervasive enteric disease responsible for large scale economic losses within the global poultry industry. The etiologic agent of NE is Clostridium perfringens (CP), an opportunistic pathogen that utilizes numerous extracellular toxins and glycoside hydrolases (GH) as key virulence and nutrient acquisition factors. Notably, some GH, mucinases, degrade components of mucin in the gastrointestinal tract as an energy source. Targeting this mechanism may serve to reduce the incidence of disease associated with CP. Two experiments were completed that evaluated mucinase vaccine targets sourced from conserved peptide sequences of carbohydrate binding module 32 of CP mucinases. In experiment 1, 37 antigen peptides were synthetically generated and used to produce hyper-immune sera, which was then evaluated for ability to obstruct CP growth in vitro. Total CFU of CP were measured at 4, 6, and 8 h incubation to determine growth rate. Peptides 4, 5, 22, 24, and 30 were selected for further in vivo testing based on conservation or the ability to inhibit CP growth by over 50% at 6 and 8 h. In experiment 2, the aforementioned peptides were conjugated to an agonistic, CD40-targetting antibody and evaluated in vivo. Broilers were given an Eimeria maxima and CP in order to induce NE and assess vaccine efficacy. Treatments included a non-vaccinated non-inoculated control, non-vaccinated inoculated control (NVIC), vaccination with peptide 4, 5, 22, 24, or 30 (VP4-VP30), or a combination of all 5 peptides (MC). There was a significant increase (P < 0.05) in the percent change in BWG relative to NVIC for vaccination with peptide 22 and MC of 18.54 and 17.43%, respectively. MC vaccinated group had the lowest lesions with a mean score of 0.63 ± 0.18. These results suggest the MC combination was the most successful in alleviating overall performance losses associated with NE-infected broilers and encourage future testing of MC in the development of an NE vaccine.
Collapse
Affiliation(s)
- A.F. Duff
- Department of Animal Sciences, The Ohio State University, Columbus, OH 43210
| | - C.N. Vuong
- Department of Poultry Science, University of Arkansas, Fayetteville, AR 72701
| | - K.L. Searer
- Department of Animal Sciences, The Ohio State University, Columbus, OH 43210
| | - W.N. Briggs
- Department of Animal Sciences, The Ohio State University, Columbus, OH 43210
| | - K.M. Wilson
- Department of Animal Sciences, The Ohio State University, Columbus, OH 43210
| | - B.M. Hargis
- Department of Poultry Science, University of Arkansas, Fayetteville, AR 72701
| | - L.R. Berghman
- Department of Veterinary Pathology, Texas A&M University, College Station, TX 77840
- Department of Poultry Science, Texas A&M University, College Station, TX 77840
| | - L.R. Bielke
- Department of Animal Sciences, The Ohio State University, Columbus, OH 43210
| |
Collapse
|
7
|
Vuong CN, Chou WK, Briggs W, Faulkner O, Wolfenden A, Jonas M, Kapczynski DR, Hargis BM, Bielke LR, Berghman LR. Crude Inactivated Influenza A Virus Adjuvated with a Bispecific Antibody Complex Targeting Chicken CD40 and AIV M2e Confers Protection Against Lethal HPAI Challenge in Chickens. Monoclon Antib Immunodiagn Immunother 2018; 37:245-251. [PMID: 30592705 DOI: 10.1089/mab.2018.0040] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
In vivo targeting an immunogen to the CD40 receptor expressed on professional antigen-presenting cells (APCs) dramatically enhances speed, magnitude, and quality of the immune response. Our previous evaluation of this strategy in poultry was limited to immunogenicity studies using CD40-targeted synthetic peptides, which demonstrated significant antigen-specific serum IgG and tracheal IgA levels <1 week after primary administration. In this study, this antibody-guided immunization strategy was modified to permit incorporation of inactivated highly pathogenic avian influenza virions (in lieu of short synthetic peptides) as the immunogen by simply mixing a bispecific antibody complex (anti-CD40/M2e) with crude inactivated virus before injection. Adjuvated avian influenza virus (AIV) induced significant hemagglutination inhibition titers up to 6 weeks postimmunization. In efficacy studies, administration of a single vaccine dose yielded 56%-64% survival against challenge with highly pathogenic H5N1, and 100% protection was achieved upon boosting. These results represent a feasible strategy to effectively target whole inactivated influenza A virus to chicken APCs, regardless of AIV clade and without phenotyping or purifying the virus from crude allantoic fluid. The data represent proof of principle for the unique prophylactic efficacy and versatility of a CD40-targeting adjuvation strategy that can in principle also be harnessed in other poultry vaccines.
Collapse
Affiliation(s)
- Christine N Vuong
- 1 Department of Veterinary Pathobiology and Texas A&M University , College Station, Texas
| | - Wen-Ko Chou
- 2 Department of Poultry Science, Texas A&M University , College Station, Texas
| | - Whitney Briggs
- 3 Department of Animal Science, The Ohio State University , Wooster, Ohio
| | - Olivia Faulkner
- 4 Department of Poultry Science, University of Arkansas , Fayetteville, Arkansas
| | - Amanda Wolfenden
- 4 Department of Poultry Science, University of Arkansas , Fayetteville, Arkansas
| | - Melina Jonas
- 5 Medion Vaccine Company , Bandung, West Java, Indonesia
| | - Darrell R Kapczynski
- 6 Exotic and Emerging Viral Diseases Research Unit, U.S. Department of Agriculture, Agricultural Research Service , Athens, Georgia
| | - Billy M Hargis
- 4 Department of Poultry Science, University of Arkansas , Fayetteville, Arkansas
| | - Lisa R Bielke
- 3 Department of Animal Science, The Ohio State University , Wooster, Ohio
| | - Luc R Berghman
- 1 Department of Veterinary Pathobiology and Texas A&M University , College Station, Texas.,2 Department of Poultry Science, Texas A&M University , College Station, Texas
| |
Collapse
|
8
|
Vuong CN, Chou WK, Kuttappan VA, Hargis BM, Bielke LR, Berghman LR. A Fast and Inexpensive Protocol for Empirical Verification of Neutralizing Epitopes in Microbial Toxins and Enzymes. Front Vet Sci 2017; 4:91. [PMID: 28660200 PMCID: PMC5468450 DOI: 10.3389/fvets.2017.00091] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/29/2017] [Accepted: 05/30/2017] [Indexed: 12/31/2022] Open
Abstract
In vivo targeting of peptides to antigen-presenting cells by use of agonistic anti-CD40 monoclonal antibodies has been used successfully as an immune response enhancing strategy. When tested in chickens, the antibody-guided platform was capable of inducing specific IgG production within 1 week postimmunization. However, use of this method beyond its initial conception as a vaccine delivery tool has not been fully exploited. In this study, Clostridium perfringens alpha-toxin was used as a model microbial toxin for epitope mapping by using the antibody-guided immunization method to generate a panel of antibodies against specific, regions of the toxin in an attempt to identify crucial determinants on the toxin which, once bound, would hinder downstream toxicity. Alpha-toxin, which possesses both hemolytic and phospholipase C (PLC) enzymatic activities, has long been known to be one of the key destructive etiological agents of necrotic enteritis disease in poultry. Previous attempts to identify crucial antigenic determinants on the toxin mediating its enzymatic activities have been performed using expensive and labor-intensive site-directed mutagenesis techniques. To create a panel of antibodies, 23 short candidate alpha-toxin peptide regions were selected in silico using B-cell epitope prediction algorithms in the public domain and were custom synthesized to load onto the antibody-guided complex for immunization in birds for antisera production. Peptide-specific antibody responses were generated against all candidate neutralizing epitopes and used for in vitro toxin neutralization tests. Antisera against all 23 peptides were able to neutralize the toxin’s hemolytic activity, with neutralization titers ranging from 80 to 320, but none were effective in blocking PLC. The novel approach of antibody-guided immunization introduces a new, inexpensive method for polyclonal IgG production and de facto identification of neutralizing epitopes in microbial toxins and enzymes within 2 weeks from in silico analysis of a putative target sequence.
Collapse
Affiliation(s)
- Christine N Vuong
- Department of Veterinary Pathobiology, Texas A&M University, College Station, TX, United States
| | - Wen-Ko Chou
- Department of Poultry Science, Texas A&M University, College Station, TX, United States
| | - Vivek A Kuttappan
- Department of Poultry Science, University of Arkansas, Fayetteville, AR, United States
| | - Billy M Hargis
- Department of Poultry Science, University of Arkansas, Fayetteville, AR, United States
| | - Lisa R Bielke
- Department of Animal Science, The Ohio State University, Columbus, OH, United States
| | - Luc R Berghman
- Department of Veterinary Pathobiology, Texas A&M University, College Station, TX, United States.,Department of Poultry Science, Texas A&M University, College Station, TX, United States
| |
Collapse
|
9
|
Chou WK, Chen CH, Vuong CN, Abi-Ghanem D, Waghela SD, Mwangi W, Bielke LR, Hargis BM, Berghman LR. Significant mucosal sIgA production after a single oral or parenteral administration using in vivo CD40 targeting in the chicken. Res Vet Sci 2016; 108:112-5. [PMID: 27663378 DOI: 10.1016/j.rvsc.2016.08.013] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/04/2015] [Revised: 08/07/2016] [Accepted: 08/30/2016] [Indexed: 10/21/2022]
Abstract
Many pathogens enter the host through mucosal surfaces and spread rapidly via the circulation. The most effective way to prevent disease is to establish mucosal and systemic immunity against the pathogen. However, current vaccination programs in poultry industry require repeated administrations of live-attenuated virus or large amounts (10 to 100μg) of antigen together with adjuvant to induce specific secretory IgA immune responses at the mucosal effector sites. In the present study, we show that a single administration of 0.4μg of oligopeptide complexed with an agonistic anti-chicken CD40 (chCD40) monoclonal antibody (Mab) effectively targets antigen-presenting cells of the bird's mucosa-associated lymphoid tissue in vivo, and induces peptide-specific secretory IgA (sIgA) in the trachea 7days post administration. Anti-chCD40 Mab-peptide complex was administered once to four-week old male Leghorns via various mucosal routes (orally, via cloacal drinking, or oculo-nasally) or via subcutaneous (s.c.) immunization. Immunization through any of the three mucosal induction routes induced significant peptide-specific mucosal sIgA responses 7 and 14days after immunization. Interestingly, s.c. injection of the complex also induced mucosal sIgA. Our data suggest in vivo targeting of CD40 as a potential adjuvant platform, particularly for the purpose of enhancing and speeding up mucosal vaccine responses in chickens, and potentially other food animals. This is the first study able to elicit specific sIgA immune responses in remote mucosal sites with a single administration of only 0.4μg of antigen.
Collapse
Affiliation(s)
- Wen-Ko Chou
- Department of Poultry Science, Texas A&M University, College Station, TX, USA
| | - Chang-Hsin Chen
- Department of Poultry Science, Texas A&M University, College Station, TX, USA
| | - Christine N Vuong
- Department of Veterinary Pathobiology, Texas A&M University, College Station, TX, USA
| | - Daad Abi-Ghanem
- Department of Poultry Science, Texas A&M University, College Station, TX, USA
| | - Suryakant D Waghela
- Department of Veterinary Pathobiology, Texas A&M University, College Station, TX, USA
| | - Waithaka Mwangi
- Department of Veterinary Pathobiology, Texas A&M University, College Station, TX, USA
| | - Lisa R Bielke
- JKS Poultry Health Laboratory, University of Arkansas, Fayetteville, AR, USA
| | - Billy M Hargis
- JKS Poultry Health Laboratory, University of Arkansas, Fayetteville, AR, USA
| | - Luc R Berghman
- Department of Poultry Science, Texas A&M University, College Station, TX, USA; Department of Veterinary Pathobiology, Texas A&M University, College Station, TX, USA.
| |
Collapse
|
10
|
Makkar SK, Rath NC, Packialakshmi B, Zhou ZY, Huff GR, Donoghue AM. Nutritional Supplement of Hatchery Eggshell Membrane Improves Poultry Performance and Provides Resistance against Endotoxin Stress. PLoS One 2016; 11:e0159433. [PMID: 27463239 PMCID: PMC4963089 DOI: 10.1371/journal.pone.0159433] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/01/2016] [Accepted: 07/01/2016] [Indexed: 12/02/2022] Open
Abstract
Eggshells are significant part of hatchery waste which consist of calcium carbonate crust, membranes, and proteins and peptides of embryonic origins along with other entrapped contaminants including microbes. We hypothesized that using this product as a nutritional additive in poultry diet may confer better immunity to the chickens in the paradigm of mammalian milk that enhances immunity. Therefore, we investigated the effect of hatchery eggshell membranes (HESM) as a short term feed supplement on growth performance and immunity of chickens under bacterial lipopolysaccharide (LPS) challenged condition. Three studies were conducted to find the effect of HESM supplement on post hatch chickens. In the first study, the chickens were fed either a control diet or diets containing 0.5% whey protein or HESM as supplement and evaluated at 5 weeks of age using growth, hematology, clinical chemistry, plasma immunoglobulins, and corticosterone as variables. The second and third studies were done to compare the effects of LPS on control and HESM fed birds at 5 weeks of age following at 4 and 24 h of treatment where the HESM was also sterilized with ethanol to deplete bacterial factors. HESM supplement caused weight gain in 2 experiments and decreased blood corticosterone concentrations. While LPS caused a significant loss in body weight at 24 h following its administration, the HESM supplemented birds showed significantly less body weight loss compared with the control fed birds. The WBC, heterophil/lymphocyte ratio, and the levels of IgG were low in chickens fed diets with HESM supplement compared with control diet group. LPS challenge increased the expression of pro-inflammatory cytokine gene IL-6 but the HESM fed birds showed its effect curtailed, also, which also, favored the up-regulation of anti-inflammatory genes compared with control diet fed chickens. Post hatch supplementation of HESM appears to improve performance, modulate immunity, and increase resistance of chickens to endotoxin.
Collapse
Affiliation(s)
- S. K. Makkar
- Poultry Production & Product Safety Research Unit, Agricultural Research Service, USDA, Fayetteville, Arkansas, United States of America
- Department of Poultry Science, University of Arkansas, Fayetteville, Arkansas, United States of America
| | - N. C. Rath
- Poultry Production & Product Safety Research Unit, Agricultural Research Service, USDA, Fayetteville, Arkansas, United States of America
- * E-mail:
| | - B. Packialakshmi
- Department of Poultry Science, University of Arkansas, Fayetteville, Arkansas, United States of America
| | - Z. Y. Zhou
- Department of Veterinary Medicine, Rongchang campus of Southwest University, Rongchang County, China
| | - G. R. Huff
- Poultry Production & Product Safety Research Unit, Agricultural Research Service, USDA, Fayetteville, Arkansas, United States of America
| | - A. M. Donoghue
- Poultry Production & Product Safety Research Unit, Agricultural Research Service, USDA, Fayetteville, Arkansas, United States of America
| |
Collapse
|